Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiebert

Showing results (761-770 of 888) with videos related to

Pageof 89
Sort By:
The Lancet. Gastroenterology & Hepatology|May 23, 2025
A 2024 global report on national policy, programmes, and progress towards hepatitis B elimination: findings from 33 hepatitis elimination profilesLindsey Hiebert-Suwondo, Jana Manning, Rania A Tohme, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 24, 1997
Identification of a nuclear matrix targeting signal in the leukemia and bone-related AML/CBF-alpha transcription factorsC Zeng, A J van Wijnen, J L Stein, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|August 22, 2024
Congenital rubella syndrome, a case seriesOlanrewaju Medu, Priyanka Mahajan, Maurice Hennink, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 21, 1998
Intranuclear targeting of AML/CBFalpha regulatory factors to nuclear matrix-associated transcriptional domainsC Zeng, S McNeil, S Pockwinse, et al.
Developmental Cell|July 18, 2018
Nrf2-Mediated Fibroblast Reprogramming Drives Cellular Senescence by Targeting the MatrisomePaul Hiebert, Mateusz S Wietecha, Michael Cangkrama, et al.
Oncotarget|July 16, 2014
Histone deacetylase inhibitor treatment induces 'BRCAness' and synergistic lethality with PARP inhibitor and cisplatin against human triple negative breast cancer cellsKyungsoo Ha, Warren Fiskus, Dong Soon Choi, et al.
Frontiers in Digital Health|August 11, 2023
An investigation of media reports of digital surveillance within the first year of the COVID-19 pandemicLeigha Comer, Lorie Donelle, Marionette Ngole, et al.
Studies in Health Technology and Informatics|February 19, 2025
Embracing the Messiness: Reflections on Co-Desiging the Co-Design of a Patient Journey DashboardNelson Shen, Melissa Hiebert, Alex Apilado, et al.
Molecular and Cellular Biology|July 27, 2000
TEL, a putative tumor suppressor, modulates cell growth and cell morphology of ras-transformed cells while repressing the transcription of stromelysin-1R Fenrick, L Wang, J Nip, et al.
Annals of Hematology|May 6, 2004
Epigenetic regulation of tumor suppressors in t(8:21)-containing AMLG Yang, W Khalaf, L van de Locht, et al.
Pageof 89

Showing results (761-770 of 888) with videos related to

Sort By:
Pageof 89
The Lancet. Gastroenterology & Hepatology|May 23, 2025
A 2024 global report on national policy, programmes, and progress towards hepatitis B elimination: findings from 33 hepatitis elimination profilesLindsey Hiebert-Suwondo, Jana Manning, Rania A Tohme, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 24, 1997
Identification of a nuclear matrix targeting signal in the leukemia and bone-related AML/CBF-alpha transcription factorsC Zeng, A J van Wijnen, J L Stein, et al.
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|August 22, 2024
Congenital rubella syndrome, a case seriesOlanrewaju Medu, Priyanka Mahajan, Maurice Hennink, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 21, 1998
Intranuclear targeting of AML/CBFalpha regulatory factors to nuclear matrix-associated transcriptional domainsC Zeng, S McNeil, S Pockwinse, et al.
Developmental Cell|July 18, 2018
Nrf2-Mediated Fibroblast Reprogramming Drives Cellular Senescence by Targeting the MatrisomePaul Hiebert, Mateusz S Wietecha, Michael Cangkrama, et al.
Oncotarget|July 16, 2014
Histone deacetylase inhibitor treatment induces 'BRCAness' and synergistic lethality with PARP inhibitor and cisplatin against human triple negative breast cancer cellsKyungsoo Ha, Warren Fiskus, Dong Soon Choi, et al.
Frontiers in Digital Health|August 11, 2023
An investigation of media reports of digital surveillance within the first year of the COVID-19 pandemicLeigha Comer, Lorie Donelle, Marionette Ngole, et al.
Studies in Health Technology and Informatics|February 19, 2025
Embracing the Messiness: Reflections on Co-Desiging the Co-Design of a Patient Journey DashboardNelson Shen, Melissa Hiebert, Alex Apilado, et al.
Molecular and Cellular Biology|July 27, 2000
TEL, a putative tumor suppressor, modulates cell growth and cell morphology of ras-transformed cells while repressing the transcription of stromelysin-1R Fenrick, L Wang, J Nip, et al.
Annals of Hematology|May 6, 2004
Epigenetic regulation of tumor suppressors in t(8:21)-containing AMLG Yang, W Khalaf, L van de Locht, et al.
Pageof 89